{"canonical":"https://abierto.us/vendors/crossject-sa-nlxzhcl3nll3","key":"NLXZHCL3NLL3","name":"CROSSJECT SA","uei":"NLXZHCL3NLL3","city":"DIJON","state":null,"awards":1,"obligated":"11291005.00","notices_won":0,"top_agency_name":"Office of Assistant Secretary for Preparedness and Response","top_naics":"541714","cage":"FBEF0","parent_name":"CROSSJECT SA","also_known_as":[],"country":"FRA","actions":2,"first_action":"2024-05-31","last_action":"2025-09-16","breakdowns":{"naics":[{"key":"541714","name":null,"awards":1,"obligated":"11291005.00"}],"agencies":[{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":1,"obligated":"11291005.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"11291005.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":1,"obligated":"11291005.00"}],"product_service_codes":[{"key":"AN13","name":null,"awards":1,"obligated":"11291005.00"}]},"awards_list":[{"award_key":"CONT_AWD_75A50122C00031_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75A50122C00031_7505_-NONE-_-NONE-/","piid":"75A50122C00031","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"NLXZHCL3NLL3","recipient_name":"CROSSJECT SA","recipient_uei":"NLXZHCL3NLL3","recipient_cage":"FBEF0","recipient_city":"DIJON","recipient_state":null,"sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2024-05-31","last_action_date":"2025-09-16","actions":2,"obligated":"11291005.00","current_total_value":"104152986.00","potential_total_value":"166245862.00","naics":"541714","psc":"AN13","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}